SCOPUS 정보 검색 플랫폼

Volumn 29, Issue 8, 2009, Pages 3393-3395

Background, reasons and benefits using the vienna protocol for the treatment of painful bone recurrences with 153Samarium-EDTMP

(3) Sinzinger, Helmut a Weiss, Konrad b Hiltunen, Jukka a

a ISOTOPIX Institute for Nuclear Medicine (Austria)

b Hospital Wr Neustadt (Austria)

Author keywords

153Sm EDTMP; Bone recurrences; Vienna protocol

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; LEXIDRONAM SAMARIUM SM 153; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; BLOOD TOXICITY; BONE CANCER; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG CONTRAINDICATION; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PALLIATIVE THERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; TREATMENT DURATION; TREATMENT RESPONSE;

ANALGESICS, NON-NARCOTIC; BONE NEOPLASMS; HUMANS; NEOPLASM RECURRENCE, LOCAL; ORGANOMETALLIC COMPOUNDS; ORGANOPHOSPHORUS COMPOUNDS; PAIN; PALLIATIVE CARE; SAMARIUM; TREATMENT OUTCOME;

EID: 68549110302 PISSN: 02507005 EISSN: None Source Type: Journal
DOI: None Document Type: Article

Times cited : (12)

References (8)

1
- 0024790419
- Samarium - 153 EDTMP therapy of disseminated skeletal metastasis
- Turner JH, Martindale A, Sorby P, Hetgerington EL, Fleay RF, Hoffmann RF and Claringbold PG: Samarium 153-EDTMP therapy of disseminated skeletal metastases. Eur J Nucl Med 15: 784-795, 1989. (Pubitemid 20047229)
- (1989) European Journal of Nuclear Medicine , vol.15 , Issue.12 , pp. 784-795
- Turner, J.H.¹ Martindale, A.A.² Sorby, P.³ Hetherington, E.L.⁴ Fleay, R.F.⁵ Hoffman, R.F.⁶ Claringbold, P.G.⁷

2
- 68549093451
- 153Sm-EDTMP therapy (Vienna Protocol)
- 153Sm-EDTMP therapy (Vienna Protocol). Europ J Nucl Med and Molec Imaging 30: 338, 2003.
- (2003) Europ J Nucl Med and Molec Imaging , vol.30 , pp. 338
- Sinzinger, H.¹ Ofluoglu, S.² Granegger, S.³

3
- 68549100684
- 153Samarium-EDTMP-pain palliation and effects beyond
- 153Samarium-EDTMP-pain palliation and effects beyond. Europ J Nucl Med 27: 86, 2000.
- (2000) Europ J Nucl Med , vol.27 , pp. 86
- Sinzinger, H.¹ Kratzik, C.² Zielinski, C.³

4
- 68549086086
- 153Sm-EDTMP therapy in prostate cancer?
- 153Sm-EDTMP therapy in prostate cancer? Eur J Nucl Med 29: 132, 2002.
- (2002) Eur J Nucl Med , vol.29 , pp. 132
- Sinzinger, H.¹ Palumbo, B.² Kratzik, C.³ Chehne, F.⁴ Palumbo, R.⁵

5
- 65649122912
- Repeated low-dose Sm-153-EDTMP therapy using the Vienna protocol is effective in pain palliation and lesion regression
- Sinzinger H, Palumbo B, Granegger S, Kratzik C, Palumbo R and Hiltunen J: Repeated low-dose Sm-153-EDTMP therapy using the Vienna protocol is effective in pain palliation and lesion regression. J Nucl Med 49: 369, 2008.
- (2008) J Nucl Med , vol.49 , pp. 369
- Sinzinger, H.¹ Palumbo, B.² Granegger, S.³ Kratzik, C.⁴ Palumbo, R.⁵ Hiltunen, J.⁶

6
- 68549129504
- 153Sm-EDTMP
- 153Sm-EDTMP. Hell J Nucl Med 6: 94-96, 2003.
- (2003) Hell J Nucl Med , vol.6 , pp. 94-96
- Sinzinger, H.¹ Weiss, K.² Granegger, S.³

7
- 55849106644
- 153Sm-lexidronam and docetaxel for the treatment of patients with hormone-refractory prostate cancer: First experience
- 153Sm-lexidronam and docetaxel for the treatment of patients with hormone-refractory prostate cancer: first experience. Cancer Biother Radiopharm 23: 609-618, 2008.
- (2008) Cancer Biother Radiopharm , vol.23 , pp. 609-618
- Suttmann, H.¹ Grgic, A.² Lehmann, J.³ Zwergel, U.⁴ Ramvadt, J.⁵ Gouverneur, E.⁶ Pinkert, J.⁷ Stöckle, M.⁸ Kirsch, C.M.⁹ Nestle, U.¹⁰

8
- 33746883985
- 153Sm lexidronam in the treatment of painful metastatic bone disease
- 153Sm lexidronam in the treatment of painful metastatic bone disease. Rev Urol 6: 3-12, 2004.
- (2004) Rev Urol , vol.6 , pp. 3-12
- Sartor, O.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.